DOW INC. DL-,01/ US2605571031 /
24/05/2024 08:04:53 | Chg. +0.04 | Volume | Bid08:06:48 | Ask08:06:48 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.69EUR | +0.08% | 0 Turnover: 0.00 |
52.26Bid Size: 650 | 53.09Ask Size: 650 | 37.01 bill.EUR | - | - |
GlobeNewswire
13/02
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
22/01
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
16/11/2023
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
11/10/2023
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
06/09/2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
17/11/2021
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year